Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 15Hyperandrogenism 6Endometrial Neoplasms 3Breast Neoplasms 3Osteoporosis 2Endometrial Hyperplasia 2Uterine Cervical Dysplasia 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Progesterone Resistance 1Obesity 1Menorrhagia 1Leiomyoma 1Infertility, Female 1Infertility 1Hot Flashes 1Gliosarcoma 1Glioblastoma 1Coronary Disease 1Cardiovascular Diseases 1Brain Neoplasms 1Anovulation 1Abortion, Spontaneous 1

Interventions

telapristone acetate 18ulipristal acetate 17Uterine Myomectomy 13vilaprisan 12Leuprolide 11relugolix 9estradiol, norethindrone drug combination 9asoprisnil 9elagolix 7Uterine Artery Embolization 7Mifepristone 7Estradiol 7Bupivacaine 7ulipristal 6Tranexamic Acid 6Saline Solution 5Norethindrone Acetate 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Letrozole 4Hysterectomy 4Vitamin B 6 3Sugars 3Misoprostol 3Lidocaine 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Leiomyoma × Progesterone × Clear all
NCT01441635 2021-07-13

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

AbbVie

Phase 2 Completed
271 enrolled 38 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡